Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etonogestrel implant bleeding patterns and satisfaction in trans men on testosterone
RBR-977kxd5Phase 4Recruiting
- Sponsor
- Hospital da Mulher Prof. Dr. José Aristodemo Pinotti - CAISM
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of etonogestrel in menstrual disorders and dysmenorrhea, sponsored by Hospital da Mulher Prof. Dr. José Aristodemo Pinotti - CAISM. Primary endpoints: Vaginal bleeding patterns and Satisfaction with contraceptive implant use. Started Dec 2024; status: recruiting.
02
Drugs
etonogestrel
03
Conditions
menstrual disordersdysmenorrhea
Beyond the preview
Go deeper on RBR-977kxd5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-977kxd5.